Apelin promotes proliferation,migration,and angiogenesis in bladder cancer by activating the FGF2/FGFR1 pathway

SU Wei; LAI Houhua; TANG Xin; ZHOU Qun; TANG Yachun; FU Hao; CHEN Xuancai

doi:10.12122/j.issn.1673-4254.2025.06.18

Abstract：Objective To investigate the role of apelin in regulating proliferation,migration and angiogenesis of bladder cancer cells and the possible regulatory mechanism.Methods GEO database was used to screen the differentially expressed genes in bladder cancer tissues and cells.Bladder cancer and paired adjacent tissues were collected from 60 patients for analysis of apelin expressions in relation to clinicopathological parameters.In cultured bladder cancer J82 cells and human umbilical vein endothelial cells(HUVECs),the effects of transfection with an apelin-overexpressing plasmid or specific siRNAs targeting apelin,fibroblast growth factor 2(FGF2)and fibroblast growth factor receptor 1(FGFR1)on proliferation and migration of J82 cells and tube formation in HUVECs were examined using plate cloning assay,Transwell assay,and angiogenesis assay;the changes in FGF2 expression and FGFR1 phosphorylation were detected using Western blotting.Results The expression level of apelin was significantly higher in bladder cancer tissues than adjacent tissues,and bladder cancer cell lines(T24 and J82)also expressed higher mRNA and protein levels of apelin than SV-HUC-1 cells.Apelin expression level in bladder cancer tissues was correlated with tumor invasion,distant metastasis and advanced TNM stages.Apelin knockdown significantly suppressed proliferation and migration of J82 cells and decreased the total angiogenic length of HUVECs.In contrast,apelin overexpression significantly promoted proliferation and migration and enhanced FGFR1 phosphorylation in J82 cells,and increased the total angiogenesis length in HUVECs,but this effects were effectively mitigated by transfection of the cells with FGF2 siRNA or FGFR1 siRNA.Conclusion High expression of apelin promotes J82 cell proliferation and migration and HUVEC angiogenesis by promoting activation of the FGF2/FGFR1 pathway.